Publicaciones (58) Publicaciones de PABLO ALVAREZ ARANEGA

2022

  1. Análisis bibliométrico de la producción científica en torno a la investigación responsable en diferentes áreas de conocimiento

    Revista Cubana de Información en Ciencias de la Salud, Vol. 33, Núm. 1

2021

  1. Las unidades de inteligencia competitiva y prospectiva como motor director de la innovación tecnológica en los sistemas sanitarios

    Journal of Economic & Business Intelligence, Núm. 3, pp. 43-49

  2. The management of scientific achievement in life sciences: A perspective from the complexity

    European Journal of Anatomy, Vol. 25, Núm. 5, pp. 615-624

2020

  1. Análisis de patentes y desarrollo territorial: Ejemplo en el ámbito Biosanitario

    Journal of Economic & Business Intelligence, Núm. 2, pp. 13-19

2019

  1. An updated review of adipose derived-mesenchymal stem cells and their applications in musculoskeletal disorders

    Expert Opinion on Biological Therapy, Vol. 19, Núm. 3, pp. 233-248

  2. Analysis of factors associated with grant for PCT national phase entries patent: A mathematical model

    European Journal of Anatomy, Vol. 23, Núm. 5, pp. 333-340

2018

  1. DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer

    European Journal of Anatomy, Vol. 22, Núm. 4, pp. 303-316

  2. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review

    Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578

2017

  1. Gastrointestinal stromal tumours: An actualized overview

    European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112

2016

  1. Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results

    Oxidative Medicine and Cellular Longevity, Vol. 2016

  2. Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells

    Archives of Medical Science, Vol. 12, Núm. 5, pp. 919-927

2015

  1. Cancer stem-cells patents in the context of their therapeutic purposes: Exploring the latest trends (2011-2015)

    Recent Patents on Regenerative Medicine, Vol. 5, Núm. 1, pp. 55-64

  2. Computer tools and collaborative translational research in the life sciences: The further advance of genomics and proteomics

    European Journal of Anatomy, Vol. 19, Núm. 2, pp. 131-137

  3. First enantiospecific syntheses of marine merosesquiterpenes neopetrosiquinones A and B: Evaluation of biological activity

    Journal of Natural Products, Vol. 78, Núm. 5, pp. 1026-1036

  4. Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells

    PLoS ONE, Vol. 10, Núm. 7

  5. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer

    AAPS Journal, Vol. 17, Núm. 4, pp. 918-929

2014

  1. ABC transporters as differentiation markers in glioblastoma cells

    Molecular Biology Reports, Vol. 41, Núm. 8, pp. 4847-4851

  2. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: Review of recent patents

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Núm. 1, pp. 21-34

  3. Cancer stem cells and their implication in breast cancer

    European Journal of Clinical Investigation, Vol. 44, Núm. 7, pp. 678-687

  4. Erratum: A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin (BioDrugs DOI : 10.1007/s40259-013-0055-0)

    BioDrugs